Covered recipient · General Payments record
RICARDO E NOVOA
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$5,216.40
- Reported across 183 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $552.20 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $133.69 | 8 |
| Janssen Pharmaceuticals, Inc | $100.81 | 1 |
| Lilly USA, LLC | $94.88 | 5 |
| Amgen Inc. | $73.92 | 4 |
| Novo Nordisk AS | $35.97 | 2 |
| GlaxoSmithKline, LLC. | $33.57 | 2 |
| Merck Sharp & Dohme Corporation | $24.67 | 1 |
| Astellas Pharma US Inc | $20.11 | 1 |
| Acerta Pharma LLC | $19.04 | 1 |
| PFIZER INC. | $15.54 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.95 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105135432 | CMS |
| ABBVIE INC. | $5.63 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105135434 | CMS |
| ABBVIE INC. | $2.01 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105135436 | CMS |
| ABBVIE INC. | $31.77 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105135438 | CMS |
| ABBVIE INC. | $23.39 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105135440 | CMS |
| ABBVIE INC. | $26.34 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105135442 | CMS |
| ABBVIE INC. | $4.93 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105135444 | CMS |
| ABBVIE INC. | $22.67 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105135446 | CMS |
| Amgen Inc. | $17.74 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117643181 | CMS |
| Amgen Inc. | $18.72 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115974745 | CMS |
| Amgen Inc. | $16.48 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117643183 | CMS |
| Amgen Inc. | $20.98 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117643185 | CMS |
| Astellas Pharma US Inc | $20.11 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139367461 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.04 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104300980 | CMS |
| GlaxoSmithKline, LLC. | $15.64 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116073386 | CMS |
| GlaxoSmithKline, LLC. | $17.93 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116272104 | CMS |
| Janssen Pharmaceuticals, Inc | $100.81 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077959344 | CMS |
| Lilly USA, LLC | $20.60 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135356807 | CMS |
| Lilly USA, LLC | $15.33 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135386183 | CMS |
| Lilly USA, LLC | $18.01 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135333919 | CMS |
| Lilly USA, LLC | $22.93 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135374696 | CMS |
| Lilly USA, LLC | $18.01 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135363849 | CMS |
| Merck Sharp & Dohme LLC | $24.67 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141706758 | CMS |
| Novo Nordisk Inc | $20.39 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097369532 | CMS |
| Novo Nordisk Inc | $15.58 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096599301 | CMS |
| PFIZER INC. | $15.54 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131265641 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.